DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FENTANYL CITRATE

« Back to Dashboard

Clinical Trials for Fentanyl Citrate

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00105287	Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients	Completed	Cephalon	Phase 3	The purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl when used long-term to relieve breakthrough pain in opioid tolerant cancer patients.
NCT00105937	OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients	Completed	Cephalon	Phase 3	The purpose of this study is to evaluate the long-term safety and efficacy of OraVescent fentanyl to treat breakthrough pain episodes in cancer patients who are already opioid tolerant.
NCT00125801	The Pain Pen for Breakthrough Cancer Pain	Terminated	Erasmus Medical Center	Phase 3	The purpose of this study is to see whether injection of hydromorphone through a subcutaneous injection device is more effective in treating breakthrough cancer pain than oral morphine.
NCT00209534	A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy	Completed	Bio Analytical Research Corporation	Phase 2	This study was designed to assess the safety and efficacy of AQUAVAN® Injection in providing adequate sedation in patients undergoing colonoscopy. Prior to the procedure, patients received fentanyl citrate for pain management followed five minutes later by AQUAVAN® Injection for sedation. Throughout the procedure, study personnel assessed the patient's vital signs and depth of sedation. After the procedure, the patient, physician, and an evaluator were asked to complete satisfaction surveys.
NCT00209534	A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy	Completed	HHI Clinical Research (Biostatistics)	Phase 2	This study was designed to assess the safety and efficacy of AQUAVAN® Injection in providing adequate sedation in patients undergoing colonoscopy. Prior to the procedure, patients received fentanyl citrate for pain management followed five minutes later by AQUAVAN® Injection for sedation. Throughout the procedure, study personnel assessed the patient's vital signs and depth of sedation. After the procedure, the patient, physician, and an evaluator were asked to complete satisfaction surveys.

Clinical Trial Conditions for Fentanyl Citrate

Condition Name

Condition Name for Fentanyl Citrate
Intervention	Trials
Pain	15
Cancer	8
Breakthrough Pain	5
Pain, Postoperative	4

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Fentanyl Citrate
Intervention	Trials
Breakthrough Pain	16
Pain, Postoperative	5
Dyspnea	3
Neoplasms	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Fentanyl Citrate

Trials by Country

Trials by Country for Fentanyl Citrate
Location	Trials
United States	186
India	6
Canada	4
Egypt	3
Puerto Rico	2

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Fentanyl Citrate
Location	Trials
New York	11
Texas	10
North Carolina	10
Florida	10
California	10

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Fentanyl Citrate

Clinical Trial Phase

Clinical Trial Phase for Fentanyl Citrate
Clinical Trial Phase	Trials
Phase 4	11
Phase 3	22
Phase 2	12

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Fentanyl Citrate
Clinical Trial Phase	Trials
Completed	37
Recruiting	9
Not yet recruiting	8

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Fentanyl Citrate

Sponsor Name

Sponsor Name for Fentanyl Citrate
Sponsor	Trials
Cephalon	11
Eisai Inc.	7
PPD	5

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Fentanyl Citrate
Sponsor	Trials
Industry	48
Other	41
NIH	2

Export unavailable in trial.
Subscribe for complete access.